Detailed answers about IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED, including incorporation, status, business activity, and accounts information.
When was IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED founded?
IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED was officially incorporated on 13 July 2001 and is registered under company number 04252328. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED?
IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED do?
IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED's registered address?
The registered office address of IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED is FIRST FLOOR, CEF BUILDING, BROOMHILL WAY, TORQUAY, DEVON, TQ2 7QN. This is the official address filed with Companies House for legal and statutory correspondence.
Is IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED financially stable?
The most recent accounts for IMMUNE MACRO - BIOTIC TECHNOLOGY UK LIMITED were made up to 31 July 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.